Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
6.76
+0.01 (0.15%)
At close: Nov 20, 2026, 4:00 PM EST
6.89
+0.13 (1.92%)
After-hours: Nov 20, 2026, 7:44 PM EST
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $390.88 million as of November 20, 2026. It is the 15,433rd most valuable company in the world and the 2,831st biggest in the United States. Its market cap has increased by 22.53% in one year.
Market Cap
390.88M
Enterprise Value
-1.93M
1-Year Change
22.53%
Global Rank
Country Rank
#2,831 United States
Category
ChartMarket Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $390.88M, an increase of 1,033.00%. That is a compound annual growth rate of 24.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 390.90M | 18.71% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 422.10M |
| CorMedix | 419.16M |
| Ovid Therapeutics | 415.21M |
| Rezolute | 411.22M |
| Tectonic Therapeutic | 405.26M |
| Tevogen | 405.20M |
| Candel Therapeutics | 395.37M |
| Eupraxia Pharmaceuticals | 391.72M |